Matthew Kippe, MD
Sports Medicine · Dartmouth, MANPI 1841491396
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (30.9%), education and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 40.3% of the total.
Across 149 payments — averaging $207.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- Catalyst Orthoscience$10K
- Kairos Surgical Inc$5K
- Zimmer Biomet$2K
- Johnson & Johnson$517
- Kerecis Limited$185
- plus $855 from 9 others
Across 7 payments — averaging $16,978 each. An ownership or investment interest held by the physician or an immediate family member.
- Catalyst Orthoscience$119K
What the payments were for
- Consulting fees$8,20827%
- Travel & lodging$9,57431%
- Food & beverage$4,77615%
- Education$8,39227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 72 | $12,482 |
| Catalyst Orthoscience | 21 | $9,809 |
| Kairos Surgical Inc | 16 | $5,454 |
| Zimmer Biomet | 18 | $1,648 |
| Johnson & Johnson | 4 | $517 |
| Kerecis Limited | 2 | $185 |
| Stryker | 3 | $182 |
| Miach Orthopaedics, Inc. | 3 | $174 |
| Medical Device Business Services, Inc. | 1 | $140 |
| Encore Medical, LP | 2 | $116 |
| Polaris Technology Solutions LLC | 2 | $69 |
| Embody, Inc. | 1 | $63 |
| Smith+Nephew | 2 | $46 |
| Axogen | 1 | $45 |
| Vericel Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,951 in reported general payments places this provider in the 80th percentile of 138 sports medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 61 | $679 |
| Ibuprofen | 23 | $208 |
| Meloxicam | 54 | $172 |
| Prednisone | 42 | $60 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Dartmouth
- Brian BusconiWorcester$684K
- Thomas WuerzWaltham$464K
- Elizabeth MatzkinBoston$182K
- Thomas GillDedham$168K
- Xinning LiBoston$109K
- Joseph CzarneckiWoburn$93K
- Sarav ShahBrighton$90K
- Miho TanakaBoston$89K
- James OholleranPeabody$82K
- Kai MithoeferDed Ham$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.